Abstract
Policies aimed at strengthening the delivery of safe, effective, and affordable medicines in Palestine have improved over the last decade. The capacity of both the public and private pharmaceutical sector in Palestine, particularly in the West Bank, has improved. However, several areas warrant increased attention both from policy and public health officials. These include the high cost of essential medicines, the lack of pharmacovigilance and safety regulations, and a monitoring and evaluation system to ensure prescribing practices and the use of medicines in the population to promote public health. Moreover, future policy and health delivery reforms should incorporate the government, the private sector, NGOs, and UNRWA, especially concerning the areas of payment and reimbursement systems, medicine supply chain, and the cost of medicines. This is important considering the largest payer of health care are households and that the vast majority of the population utilize services from the private sector, including local pharmacies.
Similar content being viewed by others
Abbreviations
- ADE:
-
Adverse drug events
- API:
-
Active pharmaceutical ingredients
- CAM:
-
Complementary and alternative medicine
- CDS:
-
Central drug store
- DDCR:
-
Drug Control and Registration Department
- Directorate:
-
General Directorate of Pharmacy
- EML:
-
Essential medicines list
- EU:
-
European Union
- GDP:
-
Gross domestic product
- GHI:
-
Government Health insurance
- GMP:
-
Good manufacturing practices
- IMOH:
-
Israel’s Ministry of Health
- MOH:
-
Palestinian Ministry of Health
- MOSA:
-
Ministry of Social Affairs
- NGO:
-
Nongovernmental organizations
- PCBS:
-
Palestinian Central Bureau of Statistics
- PHIC:
-
Palestinian Health Information Center
- PMMS:
-
Palestinian Military Medical Services
- PNA:
-
Palestinian National Authority
- UNRWA:
-
United Nations Relief and Works Agency
- USAID:
-
United States Agency for International Development
- USD:
-
United States dollar $
- WB:
-
World Bank
- WHO:
-
World Health Organization
References
Ali-Shtayeh MS, Jamous RM, Jamous RM (2012) Complementary and alternative medicine use amongst Palestinian diabetic patients. Complement Ther Clin Pract 18:16–21
Ali-Shtayeh MS, Jamous RM, Salameh NMY, Jamous RM, Hamadeh AMA (2016) Complementary and alternative medicine use among cancer patients in Palestine with special reference to safety-related concerns. J Ethnopharmacol 187:104–122
Almi O, The Coalition of Women for Peace, Who Profits (2012) Captive economy: the pharmaceutical industry and the Israeli occupation. Who profits
Al-Ramahi R (2012) Patterns and attitudes of self-medication practices and possible role of community pharmacists in Palestine. J Clin Pharmacol 51:562–567
Al-Ramahi R, Jaradat N, Shalalfeh R, Nasir S, Manasra Y, Shalalfeh I, Esam Y (2015) Evaluation of potential drug- herb interactions among a group of Palestinian patients with chronic diseases. BMC Complement Altern Med 15:221
Bake R (2012) Middle East. In: Phake: the deadly world of falsified and substandard medicines. Rowman & Littlefield Publishing Group, Lanham
Comité Nacional Unrwa España (2013) Nakba, 67 años de exilio [Online]. http://www.unrwa.es/los-refugiados/nakba. Accessed 12 May 2016
Daher M (2015) Shortages of essential drugs in the occupied Palestinian territory: causes, coping strategies and impact on patients. World Health Organization, Ramallah, Palestine
De Ville de Goyet C, Manenti A, Carswell K, Van Ommeren M (2015) Report of a field assessment of health conditions in the occupied Palestinian territory (oPt) 22 March to 1 April 2015. World Health Organization, Geneva
Drug Control and Registration Department (2007) Guidance on pharmaceutical product registration in Palestine. Ministry of Health, Ramallah, Palestine
General Directorate of Pharmacy & Ministry of Health (2016) General Directorate of Pharmacy [Online]. Ministry of Health. http://pharmacy.moh.ps/. Accessed 11 May 2016
Giacaman R, Khatib R, Shabaneh L, Ramlawi A, Sabri B, Sabatinelli G, Khawaja M, Laurance T (2009) Health status and health services in the occupied Palestinian territory. Lancet 373:837–849
Hass A (2018) Gaza health system collapsing: 40 percent of medicine runs out. https://www.haaretz.com/middle-east-news/palestinians/.premium-gaza-health-system-collapsing-40-percent-of-medicine-runs-out-1.5803856
Health Cluster (2014) Gaza strip: joint health sector assessment report. World Health Organizaiton, Gaza
Jaradat N, Sweileh W (2003) A descriptive study of community practice in Palestine: analysis and future work. An-Najah Univ J Res 17:191
Khdour MR, Hallak HO (2012) Societal perspectives on community pharmacy services in West Bank – Palestine. Pharm Pract 10:17
Mataria A, Khatib R, Donaldson C, Bossert T, Hunter DJ, Alsayed F, Moatti J-P (2009) The health-care system: an assessment and reform agenda. Lancet 373:1207–1217
Mataria A, Raad F, Abu-Zaineh M, Donaldson C (2010) Catastrophic healthcare payments and impoverishment in the occupied Palestinian territory. Appl Health Econ Health Policy 8:393–405
Palestinian Central Bureau of Statistics (2011) Ministry of Health [online]. Nablus. http://www.pcbs.gov.ps/
Palestinian Central Bureau of Statistics (2016a) Main statistical indicators in the West Bank and Gaza Strip [online]. Palestinian Central Bureau of Statistics, Nablus. http://www.pcbs.gov.ps. Accessed 11 May 2016
Palestinian Central Bureau of Statistics (2016b) Statistical report, Palestinian health accounts 2014. Palestinian Central Bureau of Statistics, Nablus
Palestinian Health Information Center (PHIC) (2011) Health annual report Palestine 2010. Palestinian Ministry of Health, Nablus
Palestinian Health Information Center (PHIC) (2014) Health annual report Palestine 2014. Palestinian Ministry of Health, Nablus
Palestinian Ministry of Health (2011) Palestinian National Authority: pharmaceutical country profile. World Health Organization, Ramallah
Park P (2010) Lethal counterfeits [Online]. http://www.worldpolicy.org/blog/lethal-counterfeits
Qadah K, Al-Aker M, Sabbah HA (2011) Pharmacy practice in occupied Palestinian territory: reality and difficulties. Lancet. https://els-jbs-prod-cdn.literatumonline.com/pb/assets/raw/Lancet/abstracts/palestine/palestine2011-11-1411682974817.pdf
Salah H (2015) Gaza struggles with shortage of medical. Al-Monitor. Washington, DC
Schoenbaum M, Afifi AK, Deckelbaum RJ (2005) Strengthening the Palestinian health system. RAND Corporation, Santa Monica
State of Palestine Ministry of Health (2013a) Palestinian essential medicines list. Palestine Ministry of Health, Nablus
State of Palestine Ministry of Health (2013b) Therapeutic protocols 2013. In: State of Palestine Ministry of Health, Ramallah, Palestine
Sweileh WM, Sawalha AF, Zyoud SH, Al-Jabi SW, Bani Shamseh FF, Khalaf HS (2010) Storage, utilization and cost of drug products in Palestinian households. Int J Clin Pharmacol Ther 48:59–67
Sweileh WM, Zyoud SEH, Al-Haddad MS (2016) Pharmacy practice in Palestine. In: Fathelrahman A, Ibrahim M, Wertheimer A (eds) Pharmacy practice in developing countries: achievements and challenges. Elsevier, Cambridge, MA
United States Agency for International Development & International Chamber of Commerce Palestine (2013) WTO and the Palestinian pharmaceutical sector: impact assessment. Washington DC
United States Agency for International Development & Palestinian Federation of Industries (2009) The current status of industrial sector in Palestine. United states agency for international development. Ramallah, Palestine. https://www.ppu.edu/ppuittc/sites/default/files/The%20Current%20Status%20of%20the%20Industrial%20Sector%20in%20Palestine.pdf
World Bank (2009) Reforming prudently under pressure: health financing reform and the rationalization of public sector health expenditure. West Bank and Gaza health policy report. World Bank, Washington DC
World Bank (2015) GDP per capita (current US$) [online]. World Bank. http://data.worldbank.org/indicator. Accessed 11 May 2016
World Bank (2016) World development indicators: West Bank and Gaza [online]. Accessed 5 May 2018
World Health Organization (2000) Drug situation analysis for the West Bank and Gaza strip. World Health Organization, Ramallah, Palestine
World Health Organization (2006) Health system profile: Palestine. World Health Organization, Ramallah, Palestine
World Health Organization (2011) Essential medicines in Palestine. World Health Organization, Ramallah, Palestine
World Health Organization (2012) Access to essential medicines and disposables in the Gaza Strip. Jerusalem, Israel. http://www.emro.who.int/palestine-press-releases/2012/access-essential-medicines-gaza.html
World Health Organization (2013) Health conditions in the occupied Palestinian territory, including East Jerusalem, and in the occupied Syrian Golan. World Health Organization, Geneva
Younis MZ, Hamidi S, Forgione DA, Hartmann M (2009) Rational use effects of implementing an essential medicines list in West Bank, Palestinian territories. Expert Rev Pharmacoecon Outcomes Res 9:243–250
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this entry
Cite this entry
Qato, D.M., Guadamuz, J.S., Al-Shehri, B., Al-Sultan, R., Shahin, R. (2019). Pharmaceutical Sector in Palestine. In: Laher, I. (eds) Handbook of Healthcare in the Arab World. Springer, Cham. https://doi.org/10.1007/978-3-319-74365-3_64-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-74365-3_64-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-74365-3
Online ISBN: 978-3-319-74365-3
eBook Packages: Springer Reference MedicineReference Module Medicine